Top View
- Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
- Kinetics, Mechanism and Inhibition of Monoamine Oxidase
- CCDAN Search Strategies (All Antidepressants)
- Pharmaabkommen A1 E
- Antidepressants for Insomnia in Adults (Review)
- Customs Tariff - Schedule Xxi - 1
- Wo 2007/044693 A2
- (12) Patent Application Publication (10) Pub. No.: US 2005/0002865 A1 Klaveness Et Al
- WO 2014/018563 A2 30 January 2014 (30.01.2014)
- Study Protocol
- Antidepressant Drugs
- (12) Patent Application Publication (10) Pub. No.: US 2010/0226943 A1 Brennan Et Al
- Natural Products Screening for the Identification of Selective Monoamine Oxidase-B Inhibitors
- Double-Blind Randomized Controlled Study of the Efficacy and Tolerability of Two Reversible Monoamine Oxidase a Inhibitors, Pirl
- UCSF TMS and Neuromodulation Service ATHQ PATIENT NAME
- Effect of Serotonin Modulation on Dystrophin-Deficient Zebrafish Janelle M
- Appendix & Tables
- Table [1]: Definition of Reported Outcomes Study Outcome
- Treatment of Fibromyalgia Syndrome with Antidepressants a Meta-Analysis
- Antidepressants for Cocaine Dependence and Problematic Cocaine Use (Review)
- Centre for Reviews and Dissemination
- Guaiana, G., Barbui, C., Caldwell, DM, Davies, SJC, Furukawa
- WO 2015/171002 Al 12 November 2015 (12.11.2015) P O P C T
- Esketamine for Treatment-Resistant Major Depressive Disorder
- Full-Text Articles Assessed for Full-Text Articles Excluded, Eligibility (N = 78) (N = 113)
- ANTIDEPRESSANTS: Maois (P.1) 1. Mono-Amine Oxidase Inhibitors (Maois) Developed in the 1950S Are Very Effective (As Effective As
- United States Patent (19) 11 Patent Number: 5,922,341 Smith Et Al
- Antidepressants for Insomnia in Adults (Review)
- STUDY PROTOCOL ALK5461-208 Eudract Number: 2014-000380-41
- Journal of Psychopharmacology